Pinchas Cohen
Showing 1–4 of 4 transcripts.
- Milken Institute58 min
Will You Live to a Healthy 100?
Francis Collins, Nir Barzilai, Elizabeth Blackburn, Pinchas Cohen, Joon Yun
A panel of researchers and investors shifts the longevity paradigm from extending chronological lifespan to maximizing healthspan by treating aging as a primary risk factor for chronic disease. Key figures such as Nir Barzilai, Elizabeth Blackburn, and Jun Jung highlighted actionable strategies including genetic insights from centenarians, the management of senescent cells, and the development of a $7 trillion market focused on restoring homeostatic capacity. These efforts are culminating in the imminent TAME clinical trial, which aims to establish aging as an FDA-recognized disease and unlock pharmaceutical investment for drugs like Metformin and Rapamycin to extend human health by two years.
- Milken Institute46 min
A Future of Healthy Aging
Paul Irving, Pinchas Cohen, Linda Fried, Freda Lewis-Hall, Robin Mockenhaupt
A global panel convened to address the critical misalignment between rising life expectancy and stagnant healthspan, framing older adults as an underutilized human capital asset essential for the 21st-century economy. The discussion highlighted that delaying Alzheimer's onset by five years could halve annual caregiving costs and proposed a "Frieden's Triangle" strategy combining genomic risk assessment, social engagement programs, and targeted public health policies to transform prevention. To realize this vision, the group advocated for a "third demographic dividend" through a tenfold increase in federal funding, clinical trial reforms for geriatric populations, and the creation of new social institutions designed specifically for the emerging thirty-year life stage.
- Milken Institute58 min
Longevity Is Opportunity Riding the Demographic Wave (updated)
Pinchas Cohen, Michael Hodin, Dan Houston, Paul Irving, Jody Holtzman, Hasi Cohen
This event analyzes the critical intersection of rapidly aging demographics, broken retirement financial models, and the widening gap between lifespan and healthspan in the Western world. It highlights how exponential population shifts are driving a trillion-dollar market opportunity centered on Alzheimer's prevention, "encore careers," and workforce retention strategies for adults over 50. By refraging aging as a source of economic growth rather than a burden, the discussion presents nonlinear policy solutions and private sector innovations necessary to sustain global productivity and financial stability.
- Milken Institute1h 3m
Longevity Is Opportunity: Riding the Demographic Wave
Pinchas Cohen, Michael Hodin, Dan Houston, Paul Irving, Jody Holtzman, Eric Schmidt
Driven by a historic demographic inversion where the over-60 population now exceeds the under-14 group, the traditional retirement model has collapsed due to extended lifespans outpacing savings and healthcare innovations. This shift has catalyzed a $3.5 trillion market dominated by the over-50 demographic, prompting corporate leaders and investors to pivot from acute care toward prevention, wellness, and extended career engagement strategies. Organizations like BMW and emerging startups such as Neuropath are now adapting workplace structures and diagnostic technologies to address the financial, biological, and social challenges of an aging global workforce.